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Introduction
Hand eczema is a disease that is associated with an impaired quality of life. 1, 2 Until recently this was measured using generic (non-specific) health measurement instruments (like the Euroqol (EQ)-5D questionnaire 3 ) or skin-specific instruments (like the Dermatology Life Quality Index, DLQI 4 ). Although the use of these instruments might give some insight into global quality of life impairment in hand eczema patients, one might wonder whether they indicate the true extent of the impairment. 5, 6 In order to assess this properly, the disease-specific Quality Of Life in Hand Eczema Questionnaire (QOLHEQ) was designed by an international group. In 2014 the German version of the QOLHEQ was validated in a sample of hand eczema patients. It was found to be valid, reliable and reproducible in a German population. 7 Translations into several languages were made and a cross cultural international validation study was performed to make international comparison possible. 8 However, when translating a measurement instrument and applying it to a new population, such an instrument still needs to be validated for use in that new population. In this study we will report on the scale structure, single-score validity, reproducibility, change-score validity (responsiveness) and interpretability of the Dutch QOLHEQ.
Patients and methods
This study was performed according to a previously published guideline, which adheres to the guidelines developed by the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) group. 9 Here, we will describe our methods briefly. The QOLHEQ is a thirty-item questionnaire with five response categories (never, rarely, sometimes, often, all the time) assessing health-related quality of life (HRQoL) impairment, overall and concerning four subscales: Symptoms; Emotions;
Functioning; Treatment and Prevention. It was translated into Dutch using a six-step method, including forward and backward translations and pilot testing for content validity. 10 See Supplement S1 for the final Dutch version. A longitudinal design was used to assess the studied measurement properties. Patients were asked to complete the QOLHEQ and reference instruments at three time points, while their hand eczema was also clinically evaluated (see Figure 1 ).
Study population
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Patients were included if they were ≥18 years, and had hand eczema of at least one week duration, as diagnosed by a dermatologist. Patients with concomitant skin disease on other parts of the body were also eligible for inclusion. Patients with other dermatological hand disease and/or who were unable to complete questionnaires by themselves were excluded. Recruitment was performed between March 2017 and December 2018, and took place at the dermatology department of the University Medical Center Groningen (UMCG). The Medical Ethical Review Board of the UMCG confirmed that this study did not fall under the scope of the Medical Research Involving Human Subjects Act (reference: METc 2014/391).
Reference instruments
The following reference instruments were used. The questions for the hand eczema specific assessment and the assessment of change were pilot tested for content validity prior to this study. 9, 10 Hand eczema specific assessment (in Dutch, here freely translated), all with the response categories 'not at all', 'slightly', 'moderately', 'strongly', and 'very strongly': -Global anchor question: How did your hand eczema bother you in your overall health state in the past seven days? -Symptoms subscale anchor: How did the symptoms of your hand eczema (like pain, itch, fissuring, redness) bother you in the past seven days? -Emotions subscale anchor: How strong did your hand eczema affect your emotional well-being (e.g. making you angry, frustrated, or anxious about the future) in the past seven days? -Functioning subscale anchor: How strong did your hand eczema affect your functioning (e.g. Patients responded to the question 'Overall, has there been any change in how your hand eczema bothers you since the last time you completed the QOLHEQ?' using the following seven categories: much improvement, moderate improvement, minor improvement, no change, minor deterioration, moderate deterioration, much deterioration.
-Subscale change questions: similar questions were asked to assess changes in the subscales at T 2 , but phrased as 'has there been any change in how [insert subscale] bothers you since the last time you completed the QOLHEQ?' (much improvement, moderate improvement, minor improvement, no change, minor deterioration, moderate deterioration, much deterioration).
Statistical analysis
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Sample size
We used an item/subject ratio of 1:10. The QOLHEQ has 30 items, which results in a sample size of 300 subjects. 9 
Scale structure
We used techniques of modern test theory to check the scale structure (structural validity) of the Dutch QOLHEQ. An item response theory (IRT) analysis was performed testing whether the subscales of the Dutch QOLHEQ fit the assumed unidimensional Rasch model, using RUMM2030 (RummLab Pty Ltd, Duncraig, WA, Australia). Since we received a significant likelihood ratio test (p < 0.001) in all four subscales of the QOLHEQ, we applied a model with an unrestricted parameterization where the thresholds can differ across items: the partial credit model (a two-parameter logistic model for polytomous response categories. Fit to the Rasch model was determined using the χ 2 -statistic over the item-trait interaction for each item and subscale. Also, means and standard deviations (SD) of fit residuals for the item-person interaction were checked. Individual item fit was also tested with a χ 2 -test. To check for differential item functioning (DIF) an analysis of variance (ANOVA) was done according to sex and age group (median split of the study population). DIF was assumed to be clinically relevant if a mean difference of 0.5 logits was found for an item. is robust against violations of the assumptions of a multivariate normal distribution. 15 Measures of internal consistency of each subscale were reported using Cronbach's α and the Person Separation Index (PSI), given by RUMM2030. For both, values between 0.70-0 .95 were considered as evidence for good internal consistency.
Single-score validity and responsiveness (change-score validity)
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Tests on the correlation between the Dutch QOLHEQ and the reference instruments were performed on single scores (at T 0 ) and change scores (at T 2 ) using Pearson's correlation coefficient (r). Strong correlation (+++) was defined as r > 0.7, moderate correlation (++) as 0.7> r >0.4, and weak correlation (+) as 0.4> r >0.2. For the change scores, correlation differences by a minimum of 0.10 were seen as relevant. Furthermore, as recommended by COSMIN, it was tested whether correlations of changes in QOLHEQ score with changes in instruments measuring similar constructs were ≥ 0.50, and additionally whether correlations of changes in QOLHEQ score with changes in instruments measuring related, but dissimilar constructs were lower, i.e., 0.30-0.50. 16 Validity was considered to be high if <25% of hypotheses were rejected, moderate if 25-50% were rejected, and poor if >50% were rejected.
Reproducibility
Measurement error was reported with the standard error of measurement (SEM agreement ) between subjects at T 0 and unchanged subjects at T 1 . Reliability (test-retest) was reported in the same patients with the intraclass correlation coefficient, using a two-way mixed effects model for absolute agreement (ICC agreement ). 17 An ICC agreement value of >0.70 was considered acceptable. 18 
Interpretability
For single scores, cutoff values for bands indicating how hand eczema affects HRQoL were calculated using the weighted kappa (κ) coefficient of agreement between QOLHEQ scores and the global anchor and subscale anchors. In order not to underestimate the burden for patients when using the banding, we investigated the bands within a distance of 0.01 of the highest κ-values. The final band chosen was the band for which the amount of patients reporting a higher impairment according to the anchor question compared with the band was lowest. For change scores, the smallest detectable change (SDC) was calculated using the formula SCD = 1.96 * * SEM agreement . 17 The minimally important change (MIC) for 2 improvement was determined using three different anchor-based methods (see Supplement S2 regarding change score interpretability). For deterioration no MIC was determined, because too few patients deteriorated to draw sound conclusions.
Missing values
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In eight cases, the QOLHEQ was missing one item. For these, the value 0 was imputed. 7 At T 1 , four cases had skipped a whole page, containing ten QOLHEQ items. These four cases were excluded from the analyses for reproducibility. One case was missing one DLQI item. Here, the value 0 was imputed. 4 In four cases, the SKINDEX was missing one item and in one case it was missing two items. These cases were divided by 28 and 27 respectively for the calculation of the total score. Analyses were performed with IBM SPSS Statistics for Windows, Version 23.0 (IBM Corp. Armonk, NY).
Results
Three hundred patients were included in the study at baseline (T 0 ). See Figure 2 for a study flow chart. Of the n=294 patients included in the T 0 analyses, 54.4% was male. The mean age was 44.9 years. While the rating of hand eczema severity did not differ between sexes, females indicated significantly more impairment in HRQoL than males on the total QOLHEQ and all subscales, as well as on the DLQI. Detailed characteristics of the study population and mean T 0 values of the reference instruments are reported in Table 1 .
Scale structure
When running the Rasch analysis we found disordered thresholds for 10 items, across all subscales. These items were mostly affected by the categories 'rarely' and 'sometimes', indicating that the Dutch population may have problems differentiating between those categories in general. Therefore we joined those categories for all items, resulting in a scoring structure of 0-1-1-2-3 for the whole QOLHEQ. This structure fitted the Rasch model for all subscales. However, we still found relevant disordered thresholds for item 26 'Costs'. To fix this, we rescored this item to 0-1-1-1-2. See Table 2 DIF analysis showed significant uniform DIF for only one item in the Functioning subscale. Item 3 ('Home duties') showed that females have a slightly higher chance (+0.6 logits) to be impaired for this item. This seems plausible, as females are still more often involved in performing home duties then males, and corresponds to what was found in the German validation study of the QOLHEQ. 7 The CFA showed that the Dutch QOLHEQ had a good fit to the proposed SEM (see Table 3 ). Total maximum scores that can be obtained with the Dutch QOLHEQ within the Dutch population are now: total score 89; Symptoms 21; Emotions 24; Functioning 24; Treatment and Prevention 20. An SPSS syntax can be found in Supplement S3 to recode the QOLHEQ to Dutch scores.
Single-score validity and responsiveness (change-score validity)
Of the a priori formulated hypotheses for single score validity 80% was confirmed, indicating high validity of the Dutch QOLHEQ (Table 4 ). In the analysis of responsiveness n=124 cases were included because these subjects indicated that they had changed at T 2 according to the GRC scale, while being unchanged at T 1 or when compared to baseline if they were non-respondents at T 1. These therefore represented really changed patients. In these patients 64% of the a priori formulated hypotheses for change scores were confirmed, indicating a moderate responsiveness of the Dutch QOLHEQ (Table 5 ).
Reproducibility
There were n=166 cases included in the analysis for reproducibility. This concerns the unchanged patients at T 1 according to the GRC scale. The SEM agreement of the complete QOLHEQ was 5.2 points. The ICC agreement was 0.91 (95% confidence interval [CI]: 0.85-0.94), indicating good reproducibility. For the subscales we found the following values, indicating good reproducibility of all four subscales: -Symptoms: SEM agreement = 1.6 points; ICC agreement = 0.88 (95% CI: 0.84-0.91).
-Emotions: SEM agreement = 1.8 points; ICC agreement = 0.88 (95% CI: 0.82-0.92).
-Functioning: SEM agreement = 1.9 points; ICC agreement = 0.88 (95% CI: 0.80-0.92).
-Treatment and Prevention: SEM agreement = 1.5 points; ICC agreement = 0.86 (95% CI: 0.80-0.89).
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Interpretability For single scores, several bands for severity of HRQoL impairment were tested for the overall QOLHEQ score and subscales. For the overall QOLHEQ, we propose separate bands for males and females. The final band chosen for the overall QOLHEQ had a κ-value of 0.430: not at all, 0-13; slightly, 14-28; moderately, 29-44; strongly, 45-64; very strongly, ≥65. See Supplement S4 for all proposed bands and for details on the calculation of single score interpretability.
The SCD in N=166 unchanged patients at T 1 was 14.4 points for the overall QOLHEQ. The preferred MIC, obtained with the Receiver Operating Characteristic method, was 11.5. See Supplement S2 for SDC and MIC of the subscales and further details on calculations.
Discussion
In this study, we tested various measurement properties of the Dutch QOLHEQ. We proposed a scoring structure fitting a Rasch model, and demonstrated good validity and reproducibility, and moderate responsiveness. An improvement of ≥15 points within the Dutch population should be regarded as a real, important improvement.
Compared to the German version, the Dutch QOLHEQ had to be substantially rescored. A possible explanation for this is that the Dutch translation for the item 'sometimes' (Dutch: 'nu en dan ') was not optimal; possibly in Dutch it was too similar to the category 'rarely' (Dutch: 'zelden'). A future validation study could assess if another translation (for example changing 'nu en dan' to 'soms') may yield a better discrimination on the lower end of the Dutch QOLHEQ-scale. Still the Dutch translation of the QOLHEQ as presented here, fulfills the rigorous requirements of modern test theory including IRT and SEM. Therefore, it is ready to be used in any study assessing HRQoL impairments in a Dutch population of patients with hand eczema. However, when reporting QOLHEQ results of Dutch patients in future studies, both the national and international values, which were obtained for six languages in a cross-cultural validation study 8 , should be reported for the sake of international comparison.
The item 'Costs' provided the largest issues in the analysis. Subjects could not be distinguished, based on this item. The health insurance companies in the Netherlands reimburse the treatment of hand eczema, including several emollients and protective gloves made of textile. As a result, the out-of-pocket costs for Accepted Article hand eczema are often low. This may offer a good explanation as to why a large group of patients (n=161) chose 'never' for this item. We chose to keep the item in the instrument, as it may still be important for a small subgroup of patients. However, if in the future efforts would be made to reduce the amount of items in the QOLHEQ, for example to increase its ease of use, this item should be the first to be considered for removal.
Most of our a priori stated hypotheses were confirmed in the analyses for single-score validity. For the single scores, the Photoguide, as scored by physician, correlated moderately with the QOLHEQ (0.43), where we had expected it to be only weakly correlated (<0.4). However, the Photoguide, as scored by the patient, still correlated stronger with the QOLHEQ than the physician score, which was as we had hypothesized. Therefore, we do not consider this an issue. For the change scores, the QOLHEQ showed a higher or comparable responsiveness when compared to the reference instruments, indicating that the QOLHEQ was sensitive to detect change in HRQoL in hand eczema patients.
This validation study was performed using a paper QOLHEQ version. Over the last decades, digital questionnaires are increasingly used for capturing Patient Reported Outcomes (PROs), mainly because they provide direct integration into medical health records and research databases. If a paper questionnaire is adapted to an electronic version, this may alter the measurement properties of the questionnaire. 19 However, this is not always the case. 20, 21 For the QOLHEQ, consideration should be given to this in future studies.
A limitation of this study was that the identification of unchanged patients at T 1 and changed patients at T 2 was based on the memory of patients. Especially for T 2 , which was assessed 4 to 12 weeks following T 0 , a certain amount of recall bias cannot be ruled out. Another limitation was that already between T 0 and T 1 many patients (N=73) indicated a change in the impairment they perceived because of their hand eczema, limiting the sample size for reproducibility and responsiveness, although the numbers are still acceptable. 22 This clearly reflects the variable course that is often associated with the disease. A final limitation could have been the short time between T 0 and T 1 , in which subjects might have been able to recall their answers from T 0 . However, as was apparent from the number of quickly changed patients at T 1 , this short period was needed to ensure a sufficient number of eligible subjects at T 1 . Also, we believe that answers given on the 30-item long QOLHEQ will be hard to recall, even after 1-3 days.
In conclusion, the Dutch version of the QOLHEQ has shown to be a valid, reproducible and responsive instrument in the Dutch hand eczema population. We recommend its use to measure impairment of HRQoL in Dutch hand eczema patients.
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Supporting information Supplement S1. Dutch QOLHEQ. 
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